Source author record

Sicheng Zhou

Sicheng Zhou appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

3works
4topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2026arXiv

SimRPD: Optimizing Recruitment Proactive Dialogue Agents through Simulator-Based Data Evaluation and Selection

Task-oriented proactive dialogue agents play a pivotal role in recruitment, particularly for steering conversations towards specific business outcomes, such as acquiring social-media contacts for private-channel conversion. Although supervised fine-tuning and reinforcement learning have proven effective for training such agents, their performance is heavily constrained by the scarcity of high-quality, goal-oriented domain-specific training data. To address this challenge, we propose SimRPD, a three-stage framework for training recruitment proactive dialogue agents. First, we develop a high-fidelity user simulator to synthesize large-scale conversational data through multi-turn online dialogue. Then we introduce a multi-dimensional evaluation framework based on Chain-of-Intention (CoI) to comprehensively assess the simulator and effectively select high-quality data, incorporating both global-level and instance-level metrics. Finally, we train the recruitment proactive dialogue agent on the selected dataset. Experiments in a real-world recruitment scenario demonstrate that SimRPD outperforms existing simulator-based data selection strategies, highlighting its practical value for industrial deployment and its potential applicability to other business-oriented dialogue scenarios.

preprint2022arXiv

CancerBERT: a BERT model for Extracting Breast Cancer Phenotypes from Electronic Health Records

Accurate extraction of breast cancer patients' phenotypes is important for clinical decision support and clinical research. Current models do not take full advantage of cancer domain-specific corpus, whether pre-training Bidirectional Encoder Representations from Transformer model on cancer-specific corpus could improve the performances of extracting breast cancer phenotypes from texts data remains to be explored. The objective of this study is to develop and evaluate the CancerBERT model for extracting breast cancer phenotypes from clinical texts in electronic health records. This data used in the study included 21,291 breast cancer patients diagnosed from 2010 to 2020, patients' clinical notes and pathology reports were collected from the University of Minnesota Clinical Data Repository (UMN). Results: About 3 million clinical notes and pathology reports in electronic health records for 21,291 breast cancer patients were collected to train the CancerBERT model. 200 pathology reports and 50 clinical notes of breast cancer patients that contain 9,685 sentences and 221,356 tokens were manually annotated by two annotators. 20% of the annotated data was used as a test set. Our CancerBERT model achieved the best performance with macro F1 scores equal to 0.876 (95% CI, 0.896-0.902) for exact match and 0.904 (95% CI, 0.896-0.902) for the lenient match. The NER models we developed would facilitate the automated information extraction from clinical texts to further help clinical decision support. Conclusions and Relevance: In this study, we focused on the breast cancer-related concepts extraction from EHR data and obtained a comprehensive annotated dataset that contains 7 types of breast cancer-related concepts. The CancerBERT model with customized vocabulary could significantly improve the performance for extracting breast cancer phenotypes from clinical texts.

preprint2022arXiv

Predicting Cancer Treatments Induced Cardiotoxicity of Breast Cancer Patients

Cardiotoxicity induced by the breast cancer treatments (i.e., chemotherapy, targeted therapy and radiation therapy) is a significant problem for breast cancer patients. The cardiotoxicity risk for breast cancer patients receiving different treatments remains unclear. We developed and evaluated risk predictive models for cardiotoxicity in breast cancer patients using EHR data. The AUC scores to predict the CHF, CAD, CM and MI are 0.846, 0.857, 0.858 and 0.804 respectively. After adjusting for baseline differences in cardiovascular health, patients who received chemotherapy or targeted therapy appeared to have higher risk of cardiotoxicity than patients who received radiation therapy. Due to differences in baseline cardiac health across the different breast cancer treatment groups, caution is recommended in interpreting the cardiotoxic effect of these treatments.